🔎 Trials Near Me

Dachaigh › Obesity › Texas › Amarillo

Sgrùdaidhean clionaigeach Obesity ann an Amarillo, TX

Tha 10 sgrùdaidhean airson Obesity a’ lorg phàirtichean aig làraichean ann agus timcheall air Amarillo (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

A’ fastadhÌre 2
  • Amarillo Medical Specialists /ID# 282380, Amarillo
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07752979

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

A’ fastadhÌre 3
  • Amarillo Medical Specialists, Amarillo
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

A’ fastadhÌre 3
  • Amarillo Med Spec LLP, Amarillo
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07668414

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

A’ fastadhÌre 3
  • Amarillo Medical Specialists, Amarillo
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT07339423

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

A’ fastadhÌre 3
  • PharmaTex Research, LLC, Amarillo
Aoisean 45 gu 99 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07037433

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

A’ fastadhÌre 3
  • PharmaTex Research, LLC, Amarillo
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07037459

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

A’ fastadhÌre 3
  • Kailera Clinical Site, Amarillo
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

A’ fastadhÌre 3
  • Kailera Clinical Site, Amarillo
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07284875

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

A’ fastadhÌre 3
  • PharmaTex Research, LLC, Amarillo
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07567001

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

A’ fastadhÌre 1
  • Amarillo Medical Specialists, Amarillo
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Ògmh 2026 · NCT07607587

Sgrùdaidhean Obesity ann am bailtean eile

Sgrùdaidhean eile ann an Amarillo

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.